Second Opinions
Confirm or revise your patient's diagnosis or treatment with medical record and/or pathology review.
Consultations
Our experts meet with you and your patient via telemedicine to offer guidance, options & next steps.
Coordinated Medical Care
Coordinate all care if your patient chooses to travel to us for surgery or cellular therapies, etc.
ROSWELL PARK COMPREHENSIVE CANCER CENTER
See us at Arab Health 2025 · Booth: H1.B10G
Operating from a 29-acre campus near downtown Buffalo, NY, Roswell Park cared for more than 46,000 patients in the past year. Roswell Park helps set international standards in cancer care as a founding member of the National Comprehensive Cancer Network, and consistently earns patient satisfaction scores that are among the country's highest.
Buffalo, New York (NY), United States
Healthcare
People
Kimberly Sweeney
Roswell Park Comprehensive Cancer Center
Vice President of Patient Experience
Sai Yendamuri
Roswell Park Comprehensive Cancer Center
Chief Strategy Officer; SVP of Business Development & Outreach; Chair of Thoracic Surgery
Shashi Lele
Roswell Park Comprehensive Cancer Center
Medical Director, International Patients
Sunita Panesar
Roswell Park Comprehensive Cancer Center
Vice President of Strategy, Business Development & Outreach
News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
HIGHLIGHTS:
- Teams share new treatments for pediatric and adult lymphoma, leukemia, myeloma
- Topics range from exercise interventions to new CAR T and cell therapies
- Conference happening in San Diego December 7-10, 2024
20 Nov 2024
Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer
HIGHLIGHTS:
- Triple-negative breast cancer accounts for 10-20% of all breast cancers
- Study assessed a new pre-surgery immunotherapy/chemotherapy combination
- Findings appear in Journal for ImmunoTherapy of Cancer
20 Nov 2024
Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma
HIGHLIGHTS:
- Nivolumab (Opdivo) superior to brentuximab vedotin (Adcetris) in combination
- Clinical trial results expected to change the standard of care
- Study published today in The New England Journal of Medicine
20 Nov 2024
Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park
HIGHLIGHTS:
- Launched in 2003, biobank is one of the first and largest resources of its kind
- Cancer patients and healthy volunteers provide blood/tissue to enable research
- Total investment supporting state-of-the art facility on High Street nearly $10M
20 Nov 2024
Roswell Park Radiation Oncologist Highlights New Insights on Single-Fraction Radiation for Central Lung Tumors
HIGHLIGHTS:
- Dr. Mark Farrugia presenting findings today at ASTRO 2024
- Tumors located near center of lungs can present treatment challenges
- Results from single fraction of radiation on par with multi-fraction approach
20 Nov 2024
Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia
HIGHLIGHTS:
- Ziftomenib could be next targeted therapy approved to treat AML
- FDA recognized drug as a ‘breakthrough therapy’ earlier this year
- Results especially promising in patients with high-risk leukemia subtypes
20 Nov 2024
Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer
HIGHLIGHTS:
- Alternating pazopanib and bevacizumab found superior to pazopanib alone
- Strategy aims to delay onset of resistance to pazopanib
- Study reveals median progression-free survival of 23.3 months
20 Nov 2024
Final Results of Phase 2 Clinical Trial Clarify Role of JAK2 Inhibitor in Combating Acute Graft-Versus-Host Disease
HIGHLIGHTS:
- Study added pacritinib to standard sirolimus/tacrolimus regimen
- JAK2 inhibition + reducing Th1/Th17 cells does not improve GVHD prevention
- Results published in Blood, the leading hematology journal
20 Nov 2024
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park
HIGHLIGHTS
- New designation broadens potential use of vaccine as treatment for glioma
- Nationwide trials continue in adults, children with some brain tumors
- Development of SurVaxM made possible by community donations
20 Nov 2024
New Study from Roswell Park Pinpoints Cells That May Drive Treatment Resistance in Prostate Cancer
HIGHLIGHTS:
- Study clarifies the origin of castration-resistant prostate tumor cells
- Team identified major castration-resistant prostate epithelial cell group, L1
- Work may lead to new therapeutic targets to treat advanced prostate cancer
20 Nov 2024
Warren Alpert Prize Honors Renier Brentjens, MD, PhD, 3 Other Pioneers in CAR T-Cell Therapy
HIGHLIGHTS:
- The 4 scientists developed immune cells genetically engineered to treat cancer
- CAR T-cell therapy has redefined the treatment of blood cancers, saving lives
- Patients' own T cells are modified to fight tumors with greater precision
20 Nov 2024
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
HIGHLIGHTS:
- Outside expert review panel rates Roswell Park’s programs as ‘Exceptional’
- Roswell Park retains coveted NCI-designated Comprehensive Cancer Center status
- Less than 4% of cancer centers nationwide hold the designation
20 Nov 2024
Connect with us at
About
Roswell Park Comprehensive Cancer Center has served its community for more than 120 years with care characterized by its compassion, innovation and effectiveness. Founded in 1898, Roswell Park today remains the only comprehensive cancer center designated by the National Cancer Institute (NCI) in Upstate New York, and one of only four NCI-designated comprehensive cancer centers in all of New York.
The work of the Roswell Park team encompasses many different disciplines and approaches, all rooted in some aspect of how cancer affects our lives — and in how a solution today can lessen that impact tomorrow. Roswell Park has been credited with establishing the model for today’s multidisciplinary approach to cancer care. A seamless interface of scientific inquiry and clinical application affords patients access to promising breakthroughs in cancer diagnostics, technologies and therapies. We also educate the next generation of cancer experts, with hundreds of learners coming to us each year for enrichment or education opportunities ranging from shadow days and internships to clinical training, fellowships and graduate degree programs in cancer science.
The work of the Roswell Park team encompasses many different disciplines and approaches, all rooted in some aspect of how cancer affects our lives — and in how a solution today can lessen that impact tomorrow. Roswell Park has been credited with establishing the model for today’s multidisciplinary approach to cancer care. A seamless interface of scientific inquiry and clinical application affords patients access to promising breakthroughs in cancer diagnostics, technologies and therapies. We also educate the next generation of cancer experts, with hundreds of learners coming to us each year for enrichment or education opportunities ranging from shadow days and internships to clinical training, fellowships and graduate degree programs in cancer science.
